This Crispr Therapeutics Stock: Why It Fell Today So Far
Biotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
This guide shows how indices are grouped by country and region, enabling easier cross-market comparisons and analysis.
28,656 articlesBiotech investors woke up to a sharp move in this crispr therapeutics stock after CRISPR Therapeutics announced new d...
Insider activity is part of every bank’s life. This guide explains how to read Form 4 disclosures and what they may m...
A new round of claims alleges harassment at Carta, the private equity software unicorn valued near $7.4 billion. As m...
A significant leadership reshuffle at a high-profile exclusive: ozempic prescription startup signals a broader pivot ...
More than 40 analysts now rate AMD a Buy as AI-driven data center demand fuels growth. Here’s why the stock could pus...
Tesla sits at a fair-value crossroads in 2026, with capex and AI initiatives guiding a modest upside. Here’s how inve...
Terex stock surged nearly 70% in the last year, fueling headlines about strong demand in construction and industrial ...
Two aviation giants, Delta Air Lines and United Airlines, compete for your portfolio. This guide breaks down their bu...
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
A new decade of grid investment is underway, backed by policy and utility plans. Three ETFs are poised to capture the...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...